ANIX
Price
$3.75
Change
+$0.41 (+12.28%)
Updated
Jun 16, 04:59 PM (EDT)
Capitalization
107.59M
Earnings call today
REPL
Price
$9.84
Change
+$0.06 (+0.61%)
Updated
Jun 16, 04:59 PM (EDT)
Capitalization
753.91M
45 days until earnings call
Interact to see
Advertisement

ANIX vs REPL

Header iconANIX vs REPL Comparison
Open Charts ANIX vs REPLBanner chart's image
Anixa Biosciences
Price$3.75
Change+$0.41 (+12.28%)
Volume$1.01K
Capitalization107.59M
Replimune Group
Price$9.84
Change+$0.06 (+0.61%)
Volume$22.73K
Capitalization753.91M
ANIX vs REPL Comparison Chart
Loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. REPL commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Buy and REPL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (ANIX: $3.34 vs. REPL: $9.78)
Brand notoriety: ANIX and REPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 149% vs. REPL: 54%
Market capitalization -- ANIX: $107.59M vs. REPL: $753.91M
ANIX [@Biotechnology] is valued at $107.59M. REPL’s [@Biotechnology] market capitalization is $753.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $356.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileREPL’s FA Score has 1 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • REPL’s FA Score: 1 green, 4 red.
According to our system of comparison, REPL is a better buy in the long-term than ANIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 6 TA indicator(s) are bullish while REPL’s TA Score has 7 bullish TA indicator(s).

  • ANIX’s TA Score: 6 bullish, 4 bearish.
  • REPL’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, REPL is a better buy in the short-term than ANIX.

Price Growth

ANIX (@Biotechnology) experienced а +21.01% price change this week, while REPL (@Biotechnology) price change was -5.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.01%. For the same industry, the average monthly price growth was +10.36%, and the average quarterly price growth was +8.87%.

Reported Earning Dates

ANIX is expected to report earnings on Jun 16, 2025.

REPL is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-2.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REPL($754M) has a higher market cap than ANIX($108M). ANIX YTD gains are higher at: 43.966 vs. REPL (-19.240). ANIX has higher annual earnings (EBITDA): -13.11M vs. REPL (-235.43M). REPL has more cash in the bank: 484M vs. ANIX (15.6M). ANIX has less debt than REPL: ANIX (221K) vs REPL (76.2M). ANIX (0) and REPL (0) have equivalent revenues.
ANIXREPLANIX / REPL
Capitalization108M754M14%
EBITDA-13.11M-235.43M6%
Gain YTD43.966-19.240-229%
P/E RatioN/AN/A-
Revenue00-
Total Cash15.6M484M3%
Total Debt221K76.2M0%
FUNDAMENTALS RATINGS
ANIX vs REPL: Fundamental Ratings
ANIX
REPL
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
27
Undervalued
PROFIT vs RISK RATING
1..100
73100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
4046
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

REPL's Valuation (27) in the Biotechnology industry is somewhat better than the same rating for ANIX (75) in the Computer Peripherals industry. This means that REPL’s stock grew somewhat faster than ANIX’s over the last 12 months.

ANIX's Profit vs Risk Rating (73) in the Computer Peripherals industry is in the same range as REPL (100) in the Biotechnology industry. This means that ANIX’s stock grew similarly to REPL’s over the last 12 months.

ANIX's SMR Rating (97) in the Computer Peripherals industry is in the same range as REPL (98) in the Biotechnology industry. This means that ANIX’s stock grew similarly to REPL’s over the last 12 months.

ANIX's Price Growth Rating (40) in the Computer Peripherals industry is in the same range as REPL (46) in the Biotechnology industry. This means that ANIX’s stock grew similarly to REPL’s over the last 12 months.

ANIX's P/E Growth Rating (100) in the Computer Peripherals industry is in the same range as REPL (100) in the Biotechnology industry. This means that ANIX’s stock grew similarly to REPL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIXREPL
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 7 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 20 days ago
77%
Declines
ODDS (%)
Bearish Trend 27 days ago
85%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMDGX34.68-0.43
-1.22%
Fidelity Mid Cap Growth Index
FCGSX23.79-0.33
-1.37%
Fidelity Series Growth Company
KESGX15.58-0.29
-1.83%
Kennedy Capital ESG SMID Cap I
JUSSX16.77-0.32
-1.87%
JPMorgan US Small Company L
JFDRX18.18-0.38
-2.05%
JHancock Financial Industries R6

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with FDMT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then FDMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-7.22%
FDMT - ANIX
34%
Loosely correlated
-2.44%
REPL - ANIX
33%
Loosely correlated
-1.06%
KALV - ANIX
33%
Poorly correlated
-0.99%
LGND - ANIX
32%
Poorly correlated
-1.70%
RARE - ANIX
32%
Poorly correlated
-4.58%
More

REPL and

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with SNDX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then SNDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
-1.06%
SNDX - REPL
51%
Loosely correlated
-3.94%
XNCR - REPL
49%
Loosely correlated
-2.55%
IDYA - REPL
48%
Loosely correlated
-0.45%
KYMR - REPL
47%
Loosely correlated
-0.70%
SRPT - REPL
45%
Loosely correlated
-3.03%
More